摘要
新型冠状病毒肺炎(COVID-19),以发热、乏力、干咳为主要临床表现,具有强烈的传染性和流行性。结合中医传统理论,专家认为新冠肺炎属于"疫病"范畴,其病机为疫疠之邪犯肺,正邪相争,临床证候以寒湿为主,兼夹热毒,久则虚实夹杂。国家卫生健康委员会和国家中医药管理局联合推荐中西医结合防治新冠肺炎。疏风解毒胶囊(颗粒)具有清瘟解毒,宣肺泄热的功效,被推荐用于新冠肺炎医学观察期乏力伴发热或临床治疗初期。现代药理学研究显示疏风解毒胶囊具有抗病毒、抗炎和免疫调节等作用。该文主要从中医"疫病"理论、现代药理研究和临床研究等方面刍议疏风解毒胶囊防治新冠肺炎的理论依据。
Corona virus disease 2019(COVID-19),characterized by fever,fatigue and dry cough,is highly infectious and epidemic.Combined with traditional Chinese medicine(TCM)theory,COVID-19 belongs to“plague”.The pathogenesis of the disease is pestilence invading the lung and the clinical symptoms of the disease is mainly cold-dampness and noxious heat.Chinese government advise integrated the therapies of TCM and modern medicine to prevent and treat COVID-19.Shufeng Jiedu Capsule(疏风解毒胶囊)has the effects of clearing away the plague and detoxifying,and relieving lung heat,and is recommended to treat medical observation period of COVID-19 with fever.Modern pharmacological studies show that Shufeng Jiedu Capsule has antiviral,anti-inflammatory and immunomodulatory effects.The article provides theoretical basis for Shufeng Jiedu Capsule treating COVID-19 mainly from plague theory,modern pharmacological research and clinical research.
作者
陈莉
曲华
吴汉涛
史大卓
CHEN Li;QU Hua;WU Hantao;SHI Dazhuo(Peking University Traditional Chinese Medicine Clinical Medical School(Xiyuan),Beijing 100091,China;Cardiovascular Diseases Center,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing 100091,China)
出处
《辽宁中医杂志》
CAS
2021年第8期61-64,共4页
Liaoning Journal of Traditional Chinese Medicine
基金
国家自然科学基金(81603489)
“十二五”国家科技支撑计划(2013BAI02B01)
作者简介
陈莉(1992-),女,湖北黄石人,博士研究生,研究方向:中西医结合防治心血管疾病;通讯作者:史大卓(1960-),男,山东菏泽人,研究员,博士,研究方向:中西医结合防治心血管疾病,E-mail:shidztcm@163.com。
